Benzyl 4-bromophenyl ether structure
|
Common Name | Benzyl 4-bromophenyl ether | ||
---|---|---|---|---|
CAS Number | 6793-92-6 | Molecular Weight | 263.130 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 340.6±17.0 °C at 760 mmHg | |
Molecular Formula | C13H11BrO | Melting Point | 60-63 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 140.0±7.0 °C |
Name | 1-Benzyloxy-4-bromobenzene |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 340.6±17.0 °C at 760 mmHg |
Melting Point | 60-63 °C(lit.) |
Molecular Formula | C13H11BrO |
Molecular Weight | 263.130 |
Flash Point | 140.0±7.0 °C |
Exact Mass | 261.999329 |
PSA | 9.23000 |
LogP | 4.82 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.600 |
Precursor 10 | |
---|---|
DownStream 9 | |
HS Code | 2909309090 |
---|---|
Summary | 2909309090 other aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer.
Eur. J. Med. Chem. 43 , 2211-9, (2008) The estrogen receptors (ERs) are attractive targets in the treatment of breast cancer and the development of receptor-based breast cancer imaging agents for diagnostic use in biomedical imaging techni... |
|
2-Arylmethyl-1,4-benzoquinones. II. Novel inhibitors of platelet aggregation: synthesis and pharmacological evaluation.
Chem. Pharm. Bull. 45(4) , 668-74, (1997) Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation an... |
|
Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
ChemMedChem 6(8) , 1423-38, (2011) Concurrent inhibition of aromatase and steroid sulfatase (STS) may provide a more effective treatment for hormone-dependent breast cancer than monotherapy against individual enzymes, and several dual ... |
Benzene, 1-bromo-4-(phenylmethoxy)- |
1-bromo-4-phenylmethoxybenzene |
1-(Benzyloxy)-4-bromobenzene |
Benzyl 4-bromophenyl ether |
Benzyl p-bromophenyl ether |
MFCD00028016 |